Trial Financial Management White Papers & Case Studies
-
New Molecular Entities (NMEs) - The Path Of Resistance
5/3/2013
On a global scale, the number of new molecular entities (NMEs) in development—and, more importantly, the number being approved by regulatory authorities— has dropped significantly in recent years.
-
Moving Towards An Electronic Environment In Clinical Trials
5/3/2013
With each passing year, clinical trials are becoming increasingly global. The business of product development is moving away from the traditional model in which studies are conducted primarily in the US – in fact, recent estimates indicate that within the next three years, up to 65 per cent of studies under FDA regulation will be conducted outside the US. A review of a US government clinical trials registry and of 300 published reports in major medical journals revealed that one third (157 of 509) of Phase III trials were being conducted entirely outside the US, with over half the study sites (13,521 of 24,206) used in these trials located overseas, many in eastern Europe and Asia.
-
CFS Clinical Helps Top 20 Pharma Improve Investigator Payment And Budget Management While Addressing Sunshine & FMV Compliance
3/19/2013
Like its peers of all sizes operating in the United States, this Top 20 Pharma has faced the challenge of anticipating and addressing the Physician Payment Sunshine Provision (PPSP) within the Patient Protection and Affordable Care Act (PPACA) of 2009. Presented By Jim DiCesare, VP and General Manager, Contract and Regulatory Services
-
Improving Life Science Operations With Digital Signatures eBook
2/27/2013
Today, 8 of the top 10 pharmas and 6 of the top 10 CROs use ARX’s CoSign® digital signature solution to help them benefit from fully electronic regulatory document lifecycles, compliance with various FDA GxP regulations, and efficiency in supporting audits.
-
Improve Investigator Payment and Budget Management While Addressing Sunshine & FMV Compliance
2/11/2013
Like its peers of all sizes operating in the United States, this Top 20 Pharma has faced the challenge of anticipating and addressing the Physician Payment Sunshine Provision (PPSP) within the Patient Protection and Affordable Care Act (PPACA) of 2009. By CFS Clinical
-
Investigative Site Improves Financial Management Of Clinical Trials
11/2/2012
eStudySite is a San Diego-based enrollment and research organization that provides inpatient and outpatient clinical research services to pharmaceutical and contract research organizations (CROs).
-
Academic Medical Center Improves Financial Management Of Clinical Trials
11/1/2012
The Wayne State University School of Medicine is the nation’s largest single-campus medical school. Located in the Detroit Medical Center among specialty hospitals and research centers, the School of Medicine offers an ideal venue for both learning and research.
-
Grant Payment Practices: Five Requirements For Stronger Investigator Relationships
9/27/2012
In the clinical trials industry, profitability and regulatory compliance pressures continue to mount. Consequently, pharmaceutical companies are striving to maximize their research and development spending by reducing clinical trial cycle times and focusing on their core competencies—all while maintaining high standards of quality. By James M. Dicesare and Kevin T.Williams, Clinical Financial Services, LLC (CFS).
-
Leveraging Investigator Grant Payment Practices To Enhance Sponsor-Site Relationships
9/19/2012
One of the world’s leading pharmaceutical companies, AstraZeneca, has over 67,000 employees. Among those are about 13,000 at 17 principal research and development centers in eight countries — including the United States.
-
Clinical Trials Business And Financial Management Services Brochure
9/5/2012
CFS Clinical is the only company to offer turnkey business and financial management services for clinical trials. We help CROs, biopharmaceutical sponsors, and medical device companies to address today’s complex management challenges.